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Background:  Three-dimensional  speckle  tracking  echocardiography  (3D-STE)  has  a major  advantage  in
the improvement  of  accuracy  in  the  evaluation  of cardiac  chamber  volume  without  any  geometrical
assumption.  Thus,  the  aim  of this  study  was  to  use  3D-STE  to elucidate  the  features  of left  atrial  (LA)
volume  and  function  that  are  altered  by  hypertension  (HTN)  by  comparing  well-controlled  HTN  patients
with normal  subjects.
Methods: Conventional  echocardiographic  parameters  and  LA  phasic  volume  and  function  were  measured
from apical  view  by 3D-STE  in 40 patients  with well-controlled  HTN  [systolic  blood  pressure  (BP)  <140
and  diastolic  BP  <90  mmHg  for more  than  one  year]  and  40 normotensive  subjects.
Results:  The  passive  LA  emptying  function  (EF)  in the  patients  with  well-controlled  HTN  signiﬁcantly
decreased  (16  ±  7%  vs.  22  ±  8%,  p  = 0.0013)  and the active  LAEF  in  patients  with  well-controlled  HTN  sig-
niﬁcantly  increased  (35 ±  10%  vs. 30 ±  9%,  p  = 0.029)  compared  with  the values  in normotensive  subjects.
′Multivariate  logistic  regression  analysis  revealed  that  E/e was  an  independent  determinant  of  well-
controlled  HTN.  The maximum  LA  volume  index was  correlated  with elevated  E/e′ (r  = 0.30,  p =  0.0064),
whereas  the  maximum  LA volume  index  was  not  correlated  with  LV  mass  index  or systolic  BP.  This  change
was independent  of  age.
Conclusions:  These  results  suggest  that LV  diastolic  dysfunction  occurs  before  structural  changes  of  left
atrium and  left ventricle  even  in patients  with  well-controlled  HTN.
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ntroductionHypertension (HTN) causes pressure overload in the left ven-
ricle (LV) that results in LV hypertrophy, increased LV stiffness,
nd diastolic dysfunction, which increases with age [1]. Left atrial
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(LA) volume and function are thought to reﬂect LV diastolic func-
tion and may serve as useful predictors of cardiovascular outcomes
[2,3]. Thus, assessment of LA volume and function is important in
the clinical setting.
Recently, two-dimensional speckle tracking echocardiography
(2D-STE) has been used to evaluate LV and LA structure and function
using Simpson’s method with the assumption of uniform geometry
[3,4]. However, since cardiac motion is three-dimensional, 2D-STE
is limited by the geometrical assumptions required to use Simp-
son’s method [5]. In contrast, three-dimensional speckle tracking
echocardiography (3D-STE) has a major advantage in that there is
improved accuracy in the evaluation of cardiac chamber volume
vier Ltd. All rights reserved.
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ithout any geometrical assumptions [5–7]. For the left ventricle,
D-STE was shown to be superior to 2D-STE for the measurement
f LV volume and function [5–7].
We recently reported that 3D-STE allows more accurate mea-
urement of LA volume and function than 2D-STE and has high
eproducibility when it was compared with 3D-computed tomo-
raphy (CT) [8,9]. Therefore, the purpose of this study was  to use
D-STE to elucidate the features of LA volume and function that are
ltered by HTN comparing patients with well-controlled HTN and
ormotensive subjects.
ethods
tudy population and study protocol
Consecutive adults ≥20 years of age were studied in our echo-
ardiography laboratory using transthoracic echocardiography to
creen for cardiac disease in patients with well-controlled HTN for
ore than one year [systolic blood pressure (BP) <140 mmHg  and
iastolic BP <90 mmHg]. According to the guideline proposed by
ig. 1. Representative image of three-dimensional speckle tracking echocardiography 
ypertension. (B) Normotensive subject. yellow line, endocardium of left atrium; black l
ime–left atrial volume curve.ology 63 (2014) 291–295
the Japanese Society of Hypertension, two consecutive BP mea-
surements were taken from each patient in a sitting position at the
outpatient department [10]. Patients were included in this study if
they were on medical therapy for hypertension for more than one
year. Exclusion criteria were the presence of arrhythmia including
persistent or permanent atrial ﬁbrillation, a paced rhythm from an
implanted device, and moderate to severe mitral valve disease. We
also examined 40 normotensive subjects using transthoracic echo-
cardiography. The normotensive subjects included 16 volunteers
with chest pain or discomfort. All of these 40 subjects had normal
medical histories and physical examinations including echocardi-
ography. The ﬁnal study population consisted of 40 patients with
well-controlled HTN and 40 normotensive subjects.
Three-dimensional speckle tracking echocardiography3D-STE (Artida, Toshiba Medical Systems, Tochigi, Japan)
can provide a time–LA volume curve with a frame rate of
30–40 frames/second (Fig. 1). 3D-STE was  performed using a PST-
25SX with a 2–4 MHz  phased array matrix transducer (Toshiba
and time–left atrial volume curve during one cardiac cycle. (A) Well-controlled
ine, myocardium of left atrium; green line, epicardium of left atrium; broken line,
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regression analysis due to multicollinearity because there was a
signiﬁcant association between maximum LA volume index and
pre-atrial contraction LA volume index. Age was included because
age is associated with the incidence of HTN [1]. Multivariate logistic
Table 1
Clinical and conventional echocardiographic parameters.
HTN (n = 40) Normotensive
(n = 40)
p-Value
BSA, m2 1.6 ± 0.2 1.7 ± 0.2 0.34
Age, years 67 ± 13 60 ± 21 0.087
Men, % 22 (55) 22 (55) >0.99
Systolic BP, mmHg  130 ± 5 124 ± 7 <0.001
Diastolic BP, mmHg  80 ± 5 77 ± 6 0.0076
LV  mass index, g/m2 107 ± 21 91 ± 17 <0.001
LVEF, % 65 ± 8 65 ± 5 0.81
E/e′ 10.0 ± 2.2 7.5 ± 1.4 <0.001
Current smoking, n (%) 6 (15) 5 (13) 0.75
Diabetes mellitus, n (%) 3 (8) 2 (5) 0.64
Coronary artery disease, n (%) 4 (10) 0 (0) 0.12
Dyslipidemia, n (%) 4 (10) 2 (5) 0.68
ARBs or ACEIs, n (%) 22 (55) 0 (0) <0.001
Beta-blockers, n (%) 6 (15) 0 (0) 0.025
Calcium channel blockers, n (%) 18 (45) 0 (0) <0.001
Diuretics, n (%) 4 (10) 0 (0) 0.12
Anti-arrhythmic medication, n (%) 4 (10) 0 (0) 0.12N. Onishi et al. / Journal of
edical Systems). This matrix transducer, which was  originally
eveloped to assess LV volume and function can scan a user selected
olume that can be adjusted from 15 × 15◦ to 110 × 110◦ [5–7,11].
e applied this technique to assess LA volume and function. The
olume data were stored in a raw data format for further analysis.
ach 3D data set of the left atrium was displayed in multiple planes
ncluding the apical 2- and 4-chamber views. The examiner then
et several markers on the LA endocardium in the apical 2- and 4-
hamber viewing planes. The ﬁrst marker was set at the edge of the
eptal mitral valve ring and then markers were placed in a counter-
lockwise rotation around the LA to the lateral mitral valve ring in
he 4-chamber viewing plane. The same procedure was  performed
n the 2-chamber viewing plane. The software then detected the
A endocardium and the examiner selected a default thickness for
he LA myocardium (2–3 mm)  to deﬁne the LA epicardium. After
he endocardial and epicardial contours had been selected, the sys-
em performed the wall motion tracking analysis throughout the
ntire cardiac cycle. The selection of the LA shape is semi-automatic
nd the tracking process is automated. The examiner was able to
djust the results of the tracking process when needed. 3D-STE was
erformed on the complete LA myocardium using the 3D data set.
housands of tracking points on the reconstructed surfaces of the
A endocardium and epicardium were tracked and time–LA volume
urves were constructed from these data.
The time–LA volume curves were constructed in the apical view
sing 3D-STE. We  calculated LA phasic function from time–LA vol-
me  curves during sinus rhythm. Echocardiographic parameters
easured by 3D-STE were compared to assess the LA features
hat were altered by HTN. LA total emptying function (EF) (reser-
oir function) was deﬁned as (maximum LA volume − minimum
A volume)/maximum LA volume × 100%. LA passive EF (conduit
unction) was deﬁned as (maximum LA volume − pre-atrial con-
raction LA volume)/maximum LA volume × 100%. LA active EF
booster pump function) was deﬁned as (pre-atrial contraction
A volume − minimum LA volume)/pre-atrial contraction LA vol-
me  × 100%.
onventional echocardiographic parameters
LV ejection fraction, LV mass, and E/e′ were measured by
onventional echocardiography. Measurements were made using
riteria recommended by the American Society of Echocardiogra-
hy [12]. M-mode echocardiographic measurements were used to
alculate LV ejection fraction based on the Teichholz’s formula. LV
ass was calculated at end diastole using the following Devereux’s
ormula: LV mass = 0.8 × 1.04 × [(LV dimension + LV posterior wall
hickness + LV septal wall thickness) 3 − LV dimension 3] + 0.6. Tis-
ue Doppler measurement of mitral e′ wave velocity was  made at
he septal annulus. LV mass and LA volume were indexed to body
urface area. The study was approved by the Ethics Committee of
ur institution and informed consent was obtained from all patients
nd subjects before enrollment.
eliability and reproducibility of LA volume by 3D-STE
We  examined the interobserver variability of maximum LA vol-
me  measured by STE in 30 randomly selected recordings that were
easured by two observers using 3D-STE in a blinded manner. Like-
ise, we examined the intraobserver variability of maximum LA
olume in 30 randomly selected recordings that were measured
wice by one observer at a 7-day interval using 3D-STE.tatistical analysis
Data are expressed as the mean ± one standard deviation. Com-
arison of echocardiographic parameters between patients withology 63 (2014) 291–295 293
HTN and normotensive subjects was  also performed by an unpaired
t-test. Reproducibility of LA volume was examined using Ebel’s
intraclass correlation coefﬁcient. Multivariate logistic regression
analysis was  performed to identify the independent determinants
of HTN. Simple linear regression analysis was also performed to
determine the relationship among the echocardiographic parame-
ters. Statistical analyses were performed using Stat View version 5.0
(SAS Institution Inc., Cary, NC, USA). A p-value <0.05 was considered
to be signiﬁcant.
Results
Reliability and reproducibility of LA volume by 3D-STE
The intraobserver Ebel’s intraclass correlation coefﬁcient and
variability in maximum LA volume assessed by 3D-STE were 0.994
(95% conﬁdence interval: 0.987–0.997) and 1.4 ± 6.0%, respectively.
The interobserver Ebel’s intraclass correlation coefﬁcient and vari-
ability in maximum LA volume assessed by 3D-STE were 0.996 (95%
conﬁdence interval: 0.991–0.998) and 0.2 ± 4.5%, respectively.
Comparison of LA volume and function between hypertensive
patients and normotensive subjects
The representative images of the time–LA volume curves in
patients with HTN and normotensive subjects by 3D-STE are shown
in Fig. 1. The LV mass index and E/e′ measured by 3D-STE in
patients with HTN were signiﬁcantly greater than the values in
normotensive subjects (Table 1). The passive LAEF measured by
3D-STE in patients with HTN was signiﬁcantly less than the val-
ues in normotensive subjects (Table 2). The active LAEF in patients
with HTN was signiﬁcantly higher than that in normotensive sub-
jects, whereas there was  no signiﬁcant difference in the total LAEF
between patients with HTN and normotensive subjects.
Multivariate logistic regression analysis was performed using
variables with a p-value <0.001 in univariate analysis to iden-
tify the independent determinants of HTN. Pre-atrial contraction
LA volume index could not be included in the multiple logisticData are presented as mean ± SD or the number (%) of patients. HTN, hypertension;
BSA, body surface area; BP, blood pressure; LV, left ventricular; EF, ejection frac-
tion; E/e′ , the ratio of transmitral inﬂow velocity to mitral tissue velocity; ARBs,
angiotensin II receptor blockers; ACEIs, angiotensin-converting enzyme inhibitors.
294 N. Onishi et al. / Journal of Cardi
Table 2
Left atrial volume and function assessed by three-dimensional speckle tracking
echocardiography in hypertensive patients and normotensive subjects.
HTN (n = 40) Normotensive
(n = 40)
p-Value
Maximum LAVI, ml/m2 35 ± 9 29 ± 6 <0.001
Minimum LAVI, ml/m2 19 ± 6 15 ± 4 0.0015
Pre-AC LAVI, ml/m2 29 ± 8 23 ± 6 <0.001
Total LAEF, % 45 ± 9 46 ± 9 0.62
Passive LAEF, % 16 ± 7 22 ± 8 0.0013
Active LAEF, % 35 ± 10 30 ± 9 0.029
Data are presented as mean ± SD. HTN, hypertension; LAVI, left atrial volume index;
pre-AC LAVI, pre-atrial contraction left atrial volume index; LAEF, left atrial empty-
ing function.
Table 3
The independent features of hypertension based on multivariate logistic regression
analysis.
Variables Odds ratio 95% CI p-Value
Age, years 0.993 0.958–1.029 0.71
E/e′ 2.362 1.456–3.828 <0.001
LV  mass index, g/m2 1.032 0.997–1.067 0.072
Maximum LAVI, ml/m2 1.080 0.996–1.170 0.064
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oI, conﬁdence interval; E/e , the ratio of transmitral inﬂow velocity to mitral tissue
elocity; LV, left ventricular; LAVI, left atrial volume index.
egression analysis revealed that E/e′ was an independent deter-
inant of HTN (Table 3). The maximum LA volume index was
orrelated with E/e′ (r = 0.30, p = 0.0064), whereas the maximum
A volume index was not correlated with LV mass index or systolic
P (Fig. 2).
iscussion
In the present study, we found that E/e′ was altered in patients
ith well-controlled HTN, and this change was independent of age,
hereas LV mass index and maximum LA volume index measured
y 3D-STE were not independent determinants of well-controlled
TN. These results suggest the LV diastolic dysfunction occurs
efore structural changes of left atrium and left ventricle even in
atients with well-controlled HTN. We  also demonstrated that the
aximum LA volume index evaluated by 3D-STE was  associated
ith E/e′ that indicated LV diastolic dysfunction. To the best of our
nowledge, this is the ﬁrst report of the use of 3D-STE to show
he echocardiographic features that are altered by well-controlled
TN.
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LA volume and function evaluated by 3D-STE
Three-dimensional imaging represents one of the latest and
most signiﬁcant developments in the ﬁeld of echocardiography,
and this technique improves the accuracy of the echocardiographic
evaluation of cardiac chamber volumes [11,13–17]. Owing to this
development, there are several reports of the measurement of LA
phasic volume and function using 3D echocardiography as well as
2D-STE in the apical 4-chanber view [18–21]. Rohner et al. demon-
strated that LA volumes and LAEF, as assessed by conventional 3D
echocardiography, correlated well with CT measurements (r = 0.92
and r = 0.82, p < 0.001, respectively) [22]. However, there had been
no study validating accuracy in the measurement of LA volume and
function using 3D-STE. It is important to accurately assess not only
LA phasic volume but also LA phasic function, since LA enlarge-
ment and reduced LA function as assessed by echocardiography
is a robust predictor of cardiovascular outcomes [2,3,23]. 3D-STE
allows more accurate measurement of LA volume and function
than 2D-STE using 3D-CT as a gold standard [9]. In the present
study, we  used 3D-STE to evaluate LA volume and function. The
use of 3D-STE enables us to evaluate the features that are altered
by well-controlled HTN.
Comparison of LA features between hypertensive patients and
normal subjects
The present study demonstrated that the increment of maxi-
mum  LA volume index was a feature that was  altered by higher
systolic pressure in patients with well-controlled HTN than that
in the normotensive controls (<140 mmHg). The average systolic
pressure in the patients with well-controlled HTN was signiﬁcantly
higher than that in the normotensive subjects, although that in the
patients with well-controlled HTN and normotensive subjects were
below 140 mmHg  (130 ± 5 mmHg  vs. 124 ± 7 mmHg, respectively).
Previous reports showed that HTN causes pressure overload in the
left ventricle that results in LV hypertrophy, increased LV stiffness,
and diastolic dysfunction [1]. It is well known that LV relaxation is
impaired ﬁrst in diastolic dysfunction even in mild HTN [24].
Multivariate analysis in the present study revealed that E/e′
was an independent feature that was  altered by well-controlled
HTN. Previous reports showed that the LA phasic volumes are
directly exposed to LV pressure during ventricular diastole; there-
fore, increased maximum LA volume is a morphological expressionconduit function decreases and the relative contribution of the LA
booster pump function increases [26,27]. As LV ﬁlling pressure pro-
gressively increases with advancing diastolic dysfunction, the LA
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erves predominantly as a conduit [3]. In the present study, 3D-
TE, which allows more accurate measurement of LA volume and
unction than 2D-STE, revealed that active LAEF in patients with
ell-controlled HTN was signiﬁcantly greater than that in nor-
otensive subjects and passive LAEF was signiﬁcantly lower than
hat in normotensive subjects.
tudy limitations
There were several limitations to the present study. First, 3D-
TE has limitations such as low temporal resolution and random
oise that affect the ability to track speckles during the cardiac cycle
13]. Second, we evaluated only a small number of patients using
D-STE. Evaluation of LA volume and function using 3D-STE in a
arge number of patients with HTN will be required in the future.
n addition, it would be required to elucidate effects of medica-
ion for HTN using 3D-STE in a larger number of patients. Third,
omparison between patients with and without medication was
ot performed. To elucidate LA features altered by HTN, compari-
on between patients with and without medication was required.
ourthly, we  deﬁned well-controlled HTN as patients with blood
ressure (systolic BP <140 mmHg  and diastolic BP <90 mmHg) for
ore than one year. Previous blood pressure that was  measured
ore than one year before patients’ enrollment was not consid-
red in the present study. Finally, LV mass and LV systolic function
hould have been measured by either 2D- or 3D-STE using Simp-
on’s method to minimize the deviation, although we measured
VEF using Teichholz’s formula and LV mass using Devereux’s for-
ula.
onclusions
Patients with well-controlled HTN had elevated E/e′; this change
as considered as independent of age by the multivariate analysis.
hese results suggest that HTN leads to LV diastolic dysfunction
efore structural changes of left atrium and left ventricle even in
atients with well-controlled HTN.
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